Clinical Trials Logo

Ablative Fractionated Laser clinical trials

View clinical trials related to Ablative Fractionated Laser.

Filter by:
  • None
  • Page 1

NCT ID: NCT04570683 Recruiting - Immunotherapy Clinical Trials

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Start date: January 27, 2020
Phase: Early Phase 1
Study type: Interventional

The study aim is to assess the immunological and clinical response in basal cell carcinoma (BCC) treated with ablative fractionated laser (AFL) as monotherapy and compare with BCC treated with combination-therapy of AFL and the anti-PD1-drug nivolumab and with nivolumab as monotherapy.